1-6 of 6
David Grimwade, PhD, FRCPath
Close
Sort by
Journal Articles

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Nigel H Russell, MD, Alan K. Burnett, MD FRCP, Robert K Hills, DPhil, Sophie Betteridge, PhD, Michael Dennis, FRCPath, Richard Dillon, MA, MRCP, FRCPath, David Grimwade, PhD FRCPath
Journal: Blood
Blood (2016) 128 (22): 897.
https://doi.org/10.1182/blood.V128.22.897.897
Published: 2016
Journal Articles

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Edwige Voisset, PhD, Eva Moravcsik, Eva W Stratford, Amie Jaye, Christopher J Palgrave, Robert K Hills, DPhil, Paolo Salomoni, Scott C. Kogan, MD, Ellen Solomon, David Grimwade, PhD FRCPath
Journal: Blood
Blood (2016) 128 (22): 742.
https://doi.org/10.1182/blood.V128.22.742.742
Published: 2016
Journal Articles

Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis

Lucy Chilton, PhD, Christine Harrison, PhDFRCPath FMedSci, Anthony V. Moorman, PhD, Iona Ashworth, Alan K. Burnett, MD FRCP, David Grimwade, PhD FRCPath, Robert K Hills, MA MSc DPhil
Journal: Blood
Blood (2015) 126 (23): 1379.
https://doi.org/10.1182/blood.V126.23.1379.1379
Published: 2015
Journal Articles

Significance of Blast CD33 Expression for Effect of Gemtuzumab Ozogamicin at Different Doses in Adult Acute Myeloid Leukemia: Results from the UK NCRI AML16/17 Trials

Khan Naeem, PhD, Robert K. Hills, MA, MSc, DPhil, Paul Virgo, BSc,, Stephen Couzens, Nithiya Clark, Amanda Gilkes, Angela Grech, Peter Richardson, Steven Knapper, David Grimwade, PhD FRCPath, Nigel H. Russell, MD, Alan K. Burnett, MDFRCP, Sylvie Freeman, PhDFRCPath
Journal: Blood
Blood (2015) 126 (23): 320.
https://doi.org/10.1182/blood.V126.23.320.320
Published: 2015
Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD
Journal: Blood
Blood (2015) 126 (23): 563.
https://doi.org/10.1182/blood.V126.23.563.563
Published: 2015
Journal Articles

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Charlotte G Nyvold, M.Sci., PhD, Mette Oestergaard, M.Sci., PhD, Morten T Andersen, M.Sci., Jelena V Jovanovic, Veli Kairisto, M.D., PhD, Jan K Larsen, MM.Sci., Yvonne G Morgan, Dr., Ugur Ozbek, M.D., PhD, Prof., Niels Pallisgaard, M.Sci., Heike Pfeifer, M.D., David Grimwade, PhD, FRCPath, Peter Hokland, M.D., D., Med., Sci.
Journal: Blood
Blood (2009) 114 (22): 1619.
https://doi.org/10.1182/blood.V114.22.1619.1619
Published: 2009